Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

Title
Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors
Authors
Keywords
Dacarbazine, Neuroendocrine tumor, Chemotherapy, Objective response, Prognostic markers
Journal
BMC CANCER
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-08-18
DOI
10.1186/s12885-016-2642-1

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started